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Background: The present study was designed to evaluate association of psychosocial distress with cardio
metabolic risk factors and liver enzymes in Iranian children and adolescents.
Method: This nationwide study was conducted as the third survey of the school-based surveillance system that was
conducted among 5593 school students, 10–18 years in Iran. High triglyceride (TG), high fasting blood sugar (FBS), high
total cholesterol (TC), high low-density lipoprotein cholesterol (LDL-C), low high-density lipoprotein cholesterol (HDL-C),
hypertension (HTN), generalized obesity and abdominal obesity were considered as cardio metabolic risk factors and
alanine transaminase (ALT) and aspartate aminotransferase (AST) were considered as liver enzymes. Data were analyzed
using multiple logistic regression (MLR) analysis.
Result: Psychosocial distress was detected in2027 (71.2%) of boys and 1759 (63.3%) of girls. Among boys, the mean of
LDL, AST and DBP were higher and the mean FBS and HDL were lowering those with psychiatric distress than their
other counterparts. Girls with psychosocial distress had significantly higher mean of HDL and FBS than those without
psychiatric distress. Psychosocial distress significantly increased the odds of high LDL (OR = 2.36, 95%CI 1.53, 3.64), high
FBS (OR = 1.23, 95%CI 1.02, 1.49) and low HDL (OR = 1.65, 95%CI 1.41, 1.95).
Conclusion: Psychosocial distress in adolescents is associated with increased risk of some cardio metabolic risk factors.
Keywords: Psychosocial distress, Cardio metabolic risk factor, AdolescentsIntroduction
In addition to socioeconomic status, genetic factors and
individual lifestyles, psychosocial parameters have sig-
nificant impact on health [1]. Psychosocial distressare
one of the most common health problems in all over the
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unless otherwise stated.(WHO) reports, one in four people develop some kind
of mental illness at some point in their lives [3].
Several studies have been conducted to evaluate men-
tal health status in Iran. Results of Emamiet al. study
on in 4599 adolescent mental health status shown that
considerable proportion of adolescent students experi-
ence mental distress with higher rates in girls com-
pared to boys [4]. First and only systematic review
among high-school students in Iran concluded that
prevalence rates of any mental distress were reported
in a wide range from 4.34% to16.6% in studies using
diagnostic instruments to 34.4% in studies using screening
instruments [5].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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creased risk of dying from cardiovascular disease (CVD)
[6]. In patients with psychotic problem the rates of med-
ical co-morbidity and premature mortality are higher
compared to general populations. This population has a
higher prevalence of CVD, metabolic syndrome (MetS)
and CVD risk factors such as diabetes, hypertension,
dyslipidemia, obesity and smoking compare to general
populations. Therefore this population has a reduced life
expectancy and higher rate of morbidity and mortality
compared to general populations. Psychosocial variables
are nontraditional risk factors of CHD (coronary heart
disease) that have often been ignored.
Because of early age of onset and the chronic course
of psychosocial distress, the prevention, detection, and
treatment of these diseases in childhood and adolescent
age is very important [7]. Limited evidence exists about
the association between psychosocial distress with cardio
metabolic risk factors in children and adolescents.
Nationwide studies revealed high prevalence of cardio
metabolic risk factors and elevated liver enzymes in
Iranian children and adolescents [8-11]. In this study
we investigated the association of psychosocial distress
with cardio metabolic risk factors and liver enzymes
among 10-18- year-old adolescents in a nationwide study
in Iran.
Methods
The data used in this study were obtained as a part of the
third national Iranian survey (2009–2010), Childhood
and Adolescence Surveillance and Prevention of Adult
Non-communicable disease (CASPIAN).
The methodology details including data collection
process and sampling frame have been reported previ-
ously [12] and here we present the methods in brief.
The present study was performed among 5593 school
students (2,812 boys and 2,781 girls) aged 10–18 years,
living in urban and rural areas in 27 provinces of Iran
who were selected via multistage-random cluster sam-
pling method. Eligible schools in our study were strati-
fied according to the information bank of the Ministry of
Health and Medical Education and then, they were selected
randomly. In selected schools, the students were se-
lected via random sampling method. A team of trained
health care professionals checked the performance of the
personnel, monitored and calibrated equipment according
to standard protocols. The Research Ethics Committee of
the Endocrine and Metabolism Research Center (EMRC)
and other relevant national regulatory organizations ap-
proved the protocol of this study. The subjects entered the
survey after obtaining written consent from their parents.
Quality control and quality assurance of the survey was
closely supervised by the Data and Safety Monitoring
Board of the project at national level.Physical examination
A team of trained research assistants conducted the
physical examination under standard protocols, and by
using calibrated instruments. Weight, height, and waist
circumference (WC) were measured. Body mass index
(BMI) was calculated from weight and height [BMI =
weight (kg)⁄height (m2)]. Systolic blood pressure (SBP)
and diastolic blood pressure (DBP) were recorded as
the first and fifth korotkoff sounds. Blood pressure (BP)
measurement were performed by using a standardized
mercury sphygmomanometer on the right arm twice
after a 15-min rest in a sitting position; and the mean
of the two measurements was considered as the sub-
ject’s BP.
Clinical and laboratory measurements
Blood samples were collected in the morning after a
12 hours overnight fasting. Fasting blood sugar (FBS),
total cholesterol (TC), high-density lipoprotein-cholesterol
(HDL-C) and triglycerides (TG) were measured enzy-
matically by auto-analyzers. Low-density lipoprotein-
cholesterol (LDL-C) was calculated in serum samples with
TG ≤ 400 mg/dl according to the Friedewald equation
[13]. Serum concentration of aspartate-aminotransferase
(AST) and alanine-aminotransferase(ALT) were measured
by standard kits (Pars Azmoun,Tehran,Iran). Biochem-
ical analysis was performed in the Central Provincial
Laboratory that following the standards of the National
Reference Laboratory, which is a collaborating center of
the World Health Organization (WHO) in Tehran. Demo-
graphic information was completed by obtaining data for
all officially enrolled students in the sampled classes from
the school record. Family based characteristics (family
history of chronic diseases [hypertension, dyslipidemia,
diabetes, and obesity], parental level of education, posses-
sing a family private car and type of home), physical activ-
ity, sedentary lifestyle, birth weight, birth order, and breast
feeding duration were assessed by an interview carried out
by parents or child by a trained researcher.
Definition of terms
Abdominal obesity was defined as waist to height ratio
(WHR) more than 0.5 [14]; HTN: either systolic or dia-
stolic BP at or above the 90th percentile for age, sex and
height; pre HTN:either systolic and/or diastolic BP be-
tween the 90th and 95th percentile in childhood had
been designated percentile for age, sex [15]; Low HDL-C:
HDL-C40(<50) mg/dl (except in boys 15–19 years old that
the cut off was <45 mg/dl) ; High TG: TG100 mg/dl was
taken as the 90th percentile value for age; High FBG: FBG
levels of ≥100 mg/dl. High cholesterol and low- density
lipoprotein cholesterol was defined according to the
recommendation by the American Heart Association
i.e. total cholesterol ≥200 mg/dl, LDL-C > 130 mg/dl [16].
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considered as BMI: 85th-95thand BMI >95th percentile
respectively [17].
In this study, we used part of Global School-based
Student Health Survey (GSHS) questionnaire from World
Health Organization (WHO) for information regarding
psychiatric distress. The validity and reliability of Farsi ver-
sion of questionnaire was approved in Zakeri et al. [18]
study. The psychiatric distress was measured by 7 ques-
tions included questions regarding worthless, angriness,
anxiety, insomnia, confusion, sadness and worried prob-
lems which are presented in Table 1. If the answer to at
least 4 out of the first 7 questions was C or D, or the
answer to 5 or more questions was B, it counts on as a pre-
dictor of having psychiatric distress.
Statistical analysis
Data were analyzed using the STATA software ver-
sion10. Quantitative variables are expressed as Means ±
SD and categorical variables are expressed as percent-
ages. Student t-test was used to compare mean differences
between quantitative variables. Association between quali-
tative variables was assessed by using Pearson Chi-square
test. Multiple logistic regressions(MLR) model was fitted
to data to determine the association between psychosocial
distressand cardio metabolic risk factors and liver enzymes
after adjusting for potential confounder including age,
sex, socio-economic status, parents education, birth order,
family history of chronic disease, breast feeding duration,
sedentary lifestyle and BMI in all abnormalities except forTable 1 List of questions to screen psychosocial
distressaccording to Global School-based Student
Health Survey (GSHS) questionnaire
Questions Response
1. During the past 6 months how often have
you felt worthless?
A. Never or rarely
2. During the past 6 months how often have
you got angry too soon?
B. Once in a week
3. During the past 6 months how often have
you felt anxious?
C. More than once
in a week
4. During the past 6 months how often have
you had a bad sleep?
D. Nearly every day
5. During the past 6 months how often have
you felt dizzy or confused?
6. During the past 12 months, have you had
2 complete weeks of sadness preventing from
your routine activities?
A. Yes
B. No
7. During the past 12 months, how often have
you been so worried about something that
you could not sleep at nights?
A. Never
B. Rarely
C. Sometimes
D. Most of the time
E. Alwaysoverweight and obesity. The results of MLR are shown
as odds ratios (OR) and 95% confidence interval (CI).
P-values less than 0.05 were considered as statistically
significant. Design of sampling was considered in all
statistical analysis.
Results
Overall 2,812 boys and 2,781 girls participated in this
cross-sectional, multi-center study. Psychosocial distress
was detected in2027 (71.2%) of boys and 1759 (63.3%) of
girls which was statistically significant (P < 0.01). Table 2
showed the baseline characteristics of participants with
versus without psychiatric distress. As presented in this
table, boys with psychosocial distress had higher mean
of age, height and BMI than boys without psychiatric
distress, but in girls only the average of age in subjects
with psychosocial distress was higher compare to sub-
jects without psychiatric distress. In both genders, the
prevalence of positive family history of diabetes, obesity,
dyslipidemias, high blood pressure, and osteoporosis was
significantly higher in those children with psychosocial
distress compared to those without it. Also, psychosocial
distress was observed in 75.7% of boys and 67.9% of girls
who worked more than 2 hours a day with computer.
Mean and standard deviation of various cardio meta-
bolic risk factors and liver enzymes according to psycho-
social distress categories by sex are presented in Table 3.
The mean of LDL, AST and DBP were higher and FBS
and HDL were lower in boys with psychiatric distress
compared to subjects without psychiatric distress. Mean
of HDL and FBS in those girls with psychiatric distress
was 44.94 ± 14.06 mg/dl and 87.63 ± 13.02 mg/dl, whereas
in girls without psychiatric distress they were 47.65 ±
14.67 mg/dl and 88.97 ± 12.19 mg/dl, respectively which
was statistically significant (P <0.05).
The OR and 95% CI of psychosocial distress associated
with cardio metabolic risk factors and elevated liver en-
zymes are shown in Table 4. As presented in this table,
psychosocial distresssignificantly increased the oddsof
elevated LDL-C (OR = 2.36, 95%CI 1.53, 3.64) and ele-
vated FBS (OR = 1.23, 95% CI 1.02, 1.49) and low HDL-
C (OR = 1.65, 95% CI 1.41, 1.95) after adjustment for
age, gender and other potential confounders. No statisti-
cally significant association was found between psycho-
social distress and overweight, general obesity, abdominal
obesity, high TG, high TC, pre HTN, HTN, high ALT and
high AST.
Discussion
In a study of 5593 students (2812 boys, 2781girls), we
found that 2027 (71.2%) of boys and 1759 (63.3%) of
girls had psychosocial distress. A previous investigation
on 4599 girls and boys from 17 and 18-years-old adoles-
cent in Tehran high school have found that 34.1% of
Table 2 Baseline characteristics of subjects according to psychosocial distressby sex: the CASPIAN-III Study
Variables Psychosocial distressin boys P-value Psychosocial distressin girls P-value
Yes No Yes No
Age (y) 14.84 ± 2.39 14.34 ± 2.53 0.001 14.85 ± 2.34 14.63 ± 2.40 0.01
BMI (kg/m2)3 19.72 ± 4.12 19.36 ± 4.10 0.04 19.24 ± 2.08 19.19 ± 4.02 0.75
Waist (cm) 68.00 ± 23.51 66.74 ± 18.65 0.18 70.24 ± 22.15 69.13 ± 12.10 0.14
Breast feeding duration (%)
No 80.6 19.4 0.004 42.4 57.6 0.69
0-6 month 74.9 25.1 37.7 62.3
6-12 month 77.5 22.5 36.1 63.9
12-18 month 68.9 31.1 34.4 65.6
18-24 month 69.4 30.6 38.2 61.8
Family history of (%)
Diabetes 69.9 30.1 0.20 61.8 38.2 0.007
Obesity 74.9 25.1 0.001 62.4 37.6 0.001
High blood lipids 74.2 25.8 0.001 63.9 36.1 0.001
Hypertension 73.2 26.8 0.001 63.8 36.2 0.001
Osteoporosis 73.1 26.9 0.01 65.9 34.1 0.001
Birth order (%)
First 71.1 28.9 0.76 61.3 38.7 0.31
Second 72.2 27.8 64.4 35.6
Third 71.6 28.4 62.0 38
Forth or more 73.4 26.6 63.3 36.7
Watching TV (%)
<2 h 67.6 32.3 0.002 60.3 39.7 0.11
>2 h 73.6 26.4 63.9 36.1
Working computer (%)
<2 h 71.1 28.9 0.04 61.4 38.6 0.002
>2 h 75.7 24.3 67.9 32.1
Father’s education (%)
Illiterate 76.6 23.4 0.01 65.5 34.5 0.07
Under diploma 71.9 28.1 57.0 43.0
University 66.5 33.5 63.1 36.9
Mother’s education (%)
Illiterate 76.2 23.8 0.01 67.3 32.7 0.01
Under diploma 71.4 28.6 62.4 37.6
University 65.7 34.3 54.7 45.3
Type of home (%)
Personal home 70.5 29.5 0.001 37.5 62.5 0.001
Rented home 79.2 20.8 65.1 34.9
Personal car (%)
Yes 71 29 0.19 61.7 38.3 0.17
No 73.2 26.8 64.2 35.8
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Table 2 Baseline characteristics of subjects according to psychosocial distressby sex: the CASPIAN-III Study (Continued)
Birth weight
<2500gr 74 26 0.04 66.6 33.4 0.16
2500-4000gr 71.1 28.9 61.8 38.2
>4000gr 78.2 21.8 65.1 34.9
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this study showed that the rate of psychiatric morbidity
was higher in girl than boy students [4]. Noorbala and
his colleagues performed a national investigation about
mental health by using General Health Questionnaire-
24items (GHQ-24) in 35,014 individuals that 11,448 sub-
jects of them were adolescents and young adults aged
15–24 years. These investigators demonstrated that psy-
chosocial distresses were detected in about a fifth of popu-
lation surveyed (25.9% of women and 14.9% of men). Also,
women experience a high risk of psychosocial distresses
than men [19]. Basirnia and his colleagues, in a systematic
review reported that prevalence rates of mental health
among high-school students in Iran are quite different
with range of 1.9% to 58.8% [5]. According to gender dis-
tribution, girls were more likely to have psychosocial dis-
tress than boys, but the results of our study showed that
boy students face to increased risk of psychosocial distress
compared to girl students. Several factors may contribute
to wide range prevalence of psychosocial distress in litera-
ture including temporal and geographical characteristics,
differences in methods and tools for screening and diagno-
sis, difference in classification system, age groups of partic-
ipants and small sample size [5,19].
We examined association between presences of mental
illness and component of metabolic syndrome in Iranian
students aged 6–18 years. After adjusting for age, gender,Table 3 Mean of cardiometabolic risk factors and liver enzym
the CASPIAN-III Study
Psychosocial distressin boys P-v
Yes No
HDL-C (mg/dl) 45.88 ± 14.64 47.91 ± 13.16 0
LDL-C (mg/dl) 87.24 ± 27.46 83.59 ± 26.60 0
TC (mg/dl) 150.86 ± 31.06 152.17 ± 32.75 0
TG (mg/dl) 94.56 ± 41.37 93.48 ± 39.61 0
SBP (mmHg) 101.61 ± 13.53 101.45 ± 13.91 0
DBP (mmHg) 65.10 ± 10.43 64.18 ± 10.57 0
FBS (mg/dl) 86.32 ± 14.28 88.56 ± 15.54 0
AST (IU/dl) 25.12 ± 14.22 23.30 ± 12.55 0
ALT(IU/dl) 17.75 ± 11.36 16.94 ± 11.43 0
HDL-C; High density lipoprotein, LDL-C; Low density lipoprotein, TC; Total cholester
FBS; Fasting blood sugar, AST; Aspartate-aminotransferase, ALT; Alanine-aminotrans
1P-values are resulted from T test.socio-economic status, parent’s education, birth order,
family history of chronic disease, breast feeding duration,
sedentary lifestyle, BMI there was direct association
between mental illness and some of the parameters of
metabolic syndrome including abdominal obesity, high
HDL, low LDL and high FBS.
There is two-way relationship between depression and
metabolic syndrome. The association between depres-
sion and component of metabolic syndrome in young
and middle- age population have been shown in cross-
sectional investigations [20-22], but the causality of this
relationship is reminded. Data from prospective studies
suggested that depression may be increased the risk of
metabolic syndrome in women [23]. In the other hand,
evidence from cohort studies showed that metabolic
syndrome can be an important factor for the develop-
ment of depression or depressive symptoms such as anx-
iety and anger in middle age population. This finding
was observed only in women [24,25].
In a prospective cohort study of 921 participants in-
cluding 538 women and 383 men in Finland, Pulkki-
Raback, found that depressive symptoms in childhood
were associated with increased the risk of metabolic
syndrome in adulthood (OR: 1.40, CI: 1.05-1.85). Also,
women with metabolic syndrome in childhood had
higher level of depressive symptoms in adulthood. No
association between metabolic syndrome and depressiones according to psychosocial distresscategories by sex:
alue1 Psychosocial distressin girls P-value1
Yes No
.005 44.94 ± 14.06 47.65 ± 14.67 <0.001
.01 82.92 ± 28.41 81.03 ± 25.55 0.17
.36 144.88 ± 31.60 147.13 ± 31.84 0.10
.55 92.70 ± 44.86 90.24 ± 43.21 0.20
.77 104.73 ± 14.38 105.22 ± 13.20 0.39
.03 66.82 ± 11.17 66.96 ± 10.98 0.74
.001 87.63 ± 13.02 88.97 ± 12.19 0.01
.004 26.95 ± 13.40 27.36 ± 13.46 0.49
.14 18.73 ± 12.45 19.06 ± 10.35 0.52
ol, TG; Triglyceride, SBP; Systolic blood pressure, DBP; Diastolic blood pressure,
ferase.
Table 4 Odds ratios (95% CI) for cardiometabolic risk
factors and liver enzymes by psychiatric distress: the
CASPIAN-III Study
Psychosocial distress (yes/no)
OR CI 95% P-value2
Overweight1
Model I3 1.05 0.90-1.22 0.47
Model II4 1.02 0.88-1.19 0.71
Model III5 1.05 0.88-1.25 0.54
General obesity
Model I 1.02 0.84-1.25 0.80
Model II 1.01 0.82-1.23 0.90
Model III 1.07 0.81-1.27 0.88
Abdominal obesity
Model I 1.01 0.94-1.29 0.20
Model II 1.12 0.95-1.31 0.15
Model III 1.15 0.96-1.38 0.10
Model IV 1.26 0.99-1.60 0.06
High LDL
Model I 2.24 1.53-3.28 0.001
Model II 2.27 1.55-3.32 0.001
Model III 2.35 1.52-3.62 0.001
Model IV 2.36 1.53-3.64 0.001
High TC
Model I 0.82 0.63-1.06 0.13
Model II 0.81 0.62-1.04 0.11
Model III 0.85 0.64-1.13 0.27
Model IV 0.84 0.63-1.12 0.23
High TG
Model I 1.11 0.88-1.40 0.35
Model II 1.09 0.86-1.38 0.44
Model III 1.06 0.82-1.36 0.65
Model IV 1.03 0.79-1.35 0.78
Low HDL
Model I 1.53 1.32-1.77 0.001
Model II 1.53 1.32-1.77 0.001
Model III 1.64 1.39-1.92 0.001
Model IV 1.65 1.41-1.95 0.001
HTN
Model I 1.08 0.14-1.38 0.53
Model II 1.08 0.84-1.40 0.51
Model III 1.28 0.96-1.72 0.09
Model IV 1.32 0.98-1.79 0.06
Pre HTN
Model I 0.99 0.79-1.24 0.95
Model II 0.99 0.79-1.24 0.96
Model III 1.12 0.86-1.45 0.38
Table 4 Odds ratios (95% CI) for cardiometabolic risk
factors and liver enzymes by psychiatric distress: the
CASPIAN-III Study (Continued)
Model IV 1.13 0.87-1.47 0.33
High FBS
Model I 1.25 1.49-1.05 0.01
Model II 1.20 1.42-1.01 0.04
Model III 1.21 1.47-1.02 0.03
Model IV 1.23 1.49-1.02 0.03
High ALT
Model I 1.20 0.84-1.72 0.31
Model II 1.23 0.86-1.77 0.25
Model III 1.39 0.86-2.26 0.17
Model IV 1.31 0.81-2.14 0.26
High AST
Model I 1.24 0.96-1.60 0.09
Model II 1.30 1.01-1.69 0.04
Model III 1.40 0.99-1.99 0.06
Model IV 1.40 0.99-2.00 0.05
1- Overweight: BMI:85th-95th; obesity: BMI > 95th; low HDL: <50 mg/dl
(except in boys 15–19 years old, that cut-off was <45 mg/dl); high LDL:>110
mg/dl; high TG:> = 100 mg/dl; high TC:>200 mg/dl; high FBS:>100 mg/dl; high
blood pressure:>95th adjusted by age, sex and height; ALT and AST > 40 IU/dl.
2- P-values are resulted from logistic regression.
3- Without adjusted (crude models).
4- adjusted for age and sex and living place and.other characteristics including
socio-economic status, parent s education, birth order, family history of chronic
disease, breast feeding duration, sedentary lifestyle.
5- Additionally adjusted for BMI in all abnormalities except for overweight
and obesity.
Qorbani et al. Journal of Diabetes & Metabolic Disorders 2014, 13:44 Page 6 of 8
http://www.jdmdonline.com/content/13/1/44was observed in men [26]. Akbaraly and colleagues cor-
roding to the results of Whitehall ΙΙ prospective cohort
study in 5232 participants (41–61 years) have suggested
that among metabolic syndrome components, the cen-
tral obesity and abnormal lipids can be predictors of de-
pressive symptoms. Hypertension had no association
and high level of FBS had inverse relationship with de-
pressive symptoms. Data from our study were consistent
with these results, but in our participants there was dir-
ect association between high FBS and mental illness
[27]. Data from the retrospective study in 1999–2006 on
4070 participants confirmed the association of certain
factors including age, ethnic/racial status, poverty, and
obesity in the diagnosis of type 2 diabetes mellitus in
children. Also, it is shown the use of antidepressants and
antipsychotics agents separately or in combination is
associated with an increased risk of a type 2 diabetes
mellitus diagnosis, weight gain and alterations in cardio
metabolic indices such as dyslipidemia and hypertension
in pediatric populations [28].
It is suggested that psychosocial factors can activate
the HPA axis. Hyper secretion of corticotrophin-
releasing hormone, adrenocortico tropic hormone and
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mote deposition of visceral adipose tissue [29]. Fat tissue
can secrete inflammatory cytokines such as interleukin 1, 6
(IL1, IL6) and tumor necrosis factor (TNF-α). It is estab-
lished that these inflammatory cytokines have been involve
in insulin resistance. Also, Toschi-Dias have reported that
cardiac sympathetic modulation and peripheral sympa-
thetic activity are increased and parasympathetic modula-
tion and heart rate variability are decreased in patients
with metabolic syndrome, anxiety and mood disturbance
[30]. Therefore, this autonomic dysfunction may explain
the increased cardiovascular risk in patients with mood
alterations.
The main limitation of this study is cross-sectional de-
sign of study which does not demonstrate the causality
of association between psychosocial distresses and the
cardio metabolic risk factors. Also, it is possible that re-
sidual confounder may interpret the association between
psychosocial distresses and cardio metabolic risk factors.
In conclusion; our findings suggest that psychosocial
distresses are associated with increased risk of cardio
metabolic risk factors in particular abdominal obesity,
high LDL, FBS and low HDL in Iranian children and
adolescents.
Strength of our study includes the large sample size
and generalizability. To our knowledge, this is the first
study in Iran and even in the Middle East and North
Africa (MENA), to examine associations of psychosocial
distresses with cardio metabolic risk factors and liver
function tests in the pediatric age group.
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